InvestLog
Back to Market返回行情

298380.KQ ABL Bio Inc.

KOEHealthcare
₩86,600+3.96%LatestMarket Cap: ₩4.85T

As of 2026-08-09 03:20

Why 298380.KQ matters now

ABL Bio Inc. (298380.KQ) is a Korea stock in Healthcare. The latest InvestLog snapshot shows ₩86,600.00 with +3.96% on the session and ₩4.85T in market capitalization.

Valuation context is available even where detailed statement rows are sparse: InvestLog currently shows P/E -240.45, gross margin 86.6%, and operating margin -31.6%.

Valuation

P/E (TTM)

-240.45

PEG

—

P/B

26.61

P/S

53.68

EV/EBITDA

-196.81

DCF Value

—

FCF Yield

0.1%

Div Yield

0.0%

Margins & Returns

Gross Margin

86.6%

Operating Margin

-31.6%

Net Margin

-26.8%

ROE

-13.8%

ROA

-8.1%

ROIC

-11.9%

Listing Info

Market

Korea

Exchange

KOE

Currency

KRW

Sector

Healthcare

Industry

Biotechnology

Country

KR

ABL Bio Inc. is a biotechnology research company based in Seongnam, South Korea. The firm is dedicated to advancing therapeutic medications, primarily concentrating its efforts on treatments for immuno-oncology and neurodegenerative conditions. Its current lineup of investigational drugs features ABL001, various cancer immunotherapies, ADCs, and ABL301.